Investigating the biological differences in acute respiratory distress syndrome (ARDS)
Proteomic and metabolomic trajectories of ARDS molecular phenotypes
This study is looking at the differences in blood proteins and substances in people with acute respiratory distress syndrome (ARDS) to find out if there are different types of ARDS that might need different treatments, helping doctors provide better care for patients like you.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of California, San Francisco NIH-funded |
| Lab location | 1 site (San Francisco, United States) |
| Project ID | NIH-11053082 on NIH RePORTER |
What this research studies
This research focuses on understanding the molecular differences in patients with acute respiratory distress syndrome (ARDS) by analyzing proteins and metabolites in their blood. The study aims to identify distinct biological subtypes of ARDS, which may respond differently to treatments. By employing advanced computational methods and observational studies, the research seeks to enhance the understanding of ARDS and improve patient outcomes. Patients with ARDS will be monitored to gather data that could lead to more personalized treatment approaches.
Who could benefit from this research
Good fit: Ideal candidates for this research are adults aged 21 and older who are diagnosed with acute respiratory distress syndrome.
Not a fit: Patients with ARDS who are younger than 21 years old or those with other unrelated respiratory conditions may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more effective treatments tailored to the specific biological subtype of ARDS a patient has.
How similar studies have performed: Previous research has shown promise in identifying biological subtypes of ARDS, indicating that this approach could lead to significant advancements in treatment.
Where this research is happening
San Francisco, United States
- University of California, San Francisco — San Francisco, United States (Active)
Researchers
- Principal investigator: Alipanah-Lechner, Narges — University of California, San Francisco
- Study coordinator: Alipanah-Lechner, Narges
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.